Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...

The word “commercial” may be on everyone’s mind after the Super Bowl. From favorites to flops, this year’s crop of Super Bowl commercials had an average cost of $8 million for a 30-second slot.

B lender is one of the most popular open-source creative tools and, equally, one of the best. Whether you’re using Blender to render models for 3D printing, or you’re learning ...

Adobe's latest update introduces Project Assets workflow, Shell parameter for primitives, adaptive subdivision, and VR camera preview enhancements. Also: The "Substance 3D Asset Library" is now fully ...

Adobe has released Substance 3D Modeler 1.19.0, bringing a suite of features aimed at streamlining the 3D modeling process. Let’s dive into the highlights of this release. Project Assets Workflow In ...

In this study, we introduce a photocurable resin through supramolecular chemistry empowered VP mediated DLP-3DP that can fabricate solid structures, provide a versatile release profile, and overcome ...

allegorithmic substance designer library, allegorithmic substance designer 2020, allegorithmic substance designer download, allegorithmic substance designer workshop scad, allegorithmic substance ...

Grab your popcorn because Demi Moore's mind-bending film "The Substance" is back in theaters! The movie, which helped earn Moore her first Golden Globe win and earn her first Oscar nomination in ...

Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid agencies to research and implement models for lowering the costs of ...

CavitOmiX AI models the molecular interactions of therapeutic compounds, predicting hidden side effects and finding new uses for existing drugs. Credit: isak55/ Getty Images NVIDIA and Innophore’s ...

Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash ...